ACADIA Pharma Executive Compensation Details Revealed

Ticker: ACAD · Form: DEF 14A · Filed: 2025-04-25T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, proxy-statement, governance

Related Tickers: ACAD

TL;DR

ACADIA Pharma's 2025 DEF 14A drops: exec comp details for 2024 are in, equity awards for Davis & Adams highlighted.

AI Summary

ACADIA Pharmaceuticals Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to key executives like Stephen R. Davis and Catherine Owen Adams, with details on their fair value and vesting conditions.

Why It Matters

This filing provides transparency into how ACADIA Pharmaceuticals compensates its top executives, which can influence investor perception and corporate governance.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and does not present new financial risks.

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose of this DEF 14A filing is to provide detailed information regarding ACADIA Pharmaceuticals Inc.'s executive compensation, director compensation, and other corporate governance matters for the fiscal year ending December 31, 2024.

Who are the named executive officers whose compensation is detailed in this filing?

The filing details compensation for named executive officers, including Stephen R. Davis and Catherine Owen Adams, among others, for the fiscal year 2024.

What types of equity awards are discussed for the executives?

The filing discusses various equity awards, including changes in fair value of equity awards, equity awards granted, and outstanding unvested equity awards, for the fiscal year 2024.

When was this DEF 14A filing submitted to the SEC?

This DEF 14A filing was submitted to the SEC on April 25, 2025.

What is the fiscal year end for ACADIA Pharmaceuticals Inc. as stated in the filing?

The fiscal year end for ACADIA Pharmaceuticals Inc. is December 31.

From the Filing

0000950170-25-058827.txt : 20250425 0000950170-25-058827.hdr.sgml : 20250425 20250425164909 ACCESSION NUMBER: 0000950170-25-058827 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20250529 FILED AS OF DATE: 20250425 DATE AS OF CHANGE: 20250425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 25874931 BUSINESS ADDRESS: STREET 1: 12830 EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 12830 EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 DEF 14A 1 acad-20250425.htm DEF 14A DEF 14A false 0001070494 DEF 14A 0001070494 acad:StephenRDavisMember 2022-01-01 2022-12-31 0001070494 acad:StephenRDavisMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 acad:StephenRDavisMember 2024-01-01 2024-12-31 0001070494 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember 2024-01-01 2024-12-31 0001070494 acad:StephenRDavisMember ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember 2024-01-01 2024-12-31 0001070494 acad:StephenRDavisMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2024-01-01 2024-12-31 0001070494 ecd:NonPeoNeoMember ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember 2021-01-01 2021-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 1 2024-01-01 2024-12-31 0001070494 ecd:NonPeoNeoMember acad:AdjustmentToCompensationFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember 2020-01-01 2020-12-31 0001070494 acad:ThomasGarnerMember 2024-12-09 0001070494 acad:StephenRDavisMember 2020-01-01 2020-12-31 0001070494 acad:StephenRDavisMember ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 2024-01-01 2024-12-31 0001070494 acad:StephenRDavisMember ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember 2022-01-01 2022-12-31 0001070494 acad:StephenRDavisMember ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember 2024-09-23 0001070494 ecd:NonPeoNeoMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 ecd:NonPeoNeoMember ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember 2024-01-01 2024-12-31 0001070494 2022-01-01 2022-12-31 0001070494 2020-01-01 2020-12-31 0001070494 acad:StephenRDavisMember 2023-01-01 2023-12-31 0001070494 acad:CatherineOwenAdamsMember 2023-01-01 2023-12-31 0001070494 acad:CatherineOwenAdamsMember 2024-01-01 2024-12-31 0001070494 ecd:NonPeoNeoMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2024-01-01 2024-12-31 0001070494 ecd:NonPeoNeoMember ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember 2024-01-01 2024-12-31 0001070494 acad:CatherineOwenAdamsMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2024-01-01 2024-12-31 0001070494 ecd:NonP

View on Read The Filing